Robot pancreas test adds second drug to tame blood sugar spikes
NCT ID NCT06422325
Summary
This study tested if adding a second drug, pramlintide, to an automated insulin delivery system could better control blood sugar after meals for people with type 1 diabetes. Thirty-three adults tried the system using insulin alone on one clinic day and insulin plus pramlintide on another. The goal was to see if the two-drug combo kept blood sugar in a healthy range more often and with fewer dangerous lows.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.